New oral multitargeted antiangiogenics in non-small-cell lung cancer treatment

Author： Gori Bruno   Ricciardi Serena   Fulvi Alberto   Del Signore Ester   de Marinis Filippo  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.8, Iss.5, 2012-05, pp. : 559-573

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erlotinib in the first-line treatment of non-small-cell lung cancer

By D'Arcangelo Manolo   Cappuzzo Federico  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 523-533

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy: still an essential player in non-small-cell lung cancer treatment?

By Ferreira Carlos Gil   Montella Tatiane Caldas   Baldotto Clarissa Seródio   Domingues Pedro Masson  

Lung Cancer Management, Vol. 2, Iss. 5, 2013-10 ,pp. : 381-390

Future Medicine

Access to resources Recommend Favorite

Targeting the Immune System in the Treatment of Non-Small-Cell Lung Cancer

By Rangachari Deepa   Brahmer Julie  

Current Treatment Options in Oncology, Vol. 14, Iss. 4, 2013-12 ,pp. : 580-594

Springer Publishing Company

Access to resources Recommend Favorite

Role of bevacizumab for the treatment of non-small-cell lung cancer

By Ramalingam Suresh   Belani Chandra P  

Future Oncology, Vol. 3, Iss. 2, 2007-04 ,pp. : 131-139

Future Medicine

Access to resources Recommend Favorite

Ethnic differences in non-small-cell lung cancer treatment: the Asian perspective

By Ahn Myung-Ju   Sun Jong-Mu   Ahn Jin Seok   Park Keunchil  

Lung Cancer Management, Vol. 2, Iss. 4, 2013-08 ,pp. : 309-315

Future Medicine

Access to resources Recommend Favorite